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Abstract There are five isoforms of the regulatory subunit for
the heterodimeric type of phosphatidylinositol 3-kinase. These
five regulatory subunit isoforms were overexpressed using an
adenovirus transfection system, and their own tyrosine phosphor-
ylations and associations with various tyrosine kinase receptors
were investigated. When overexpressed in CHO-PDGFR cells,
the associations of these regulatory subunit isoforms with the
platelet-derived growth factor receptor were similar. However,
when overexpressed in CHO-IR cells, p55Q exhibited a
significantly lower ability to bind with IRS-1 upon insulin
stimulation, as compared with other regulatory subunit isoforms.
Furthermore, p55K and p55Q were found to be tyrosine-
phosphorylated. Finally, interestingly, when overexpressed in
CHO-EGFR cells or A431 cells and stimulated with epidermal
growth factor (EGF), phosphorylated EGF receptor was detected
in p85K, p85L and p50K immunoprecipitates, but not in p55K and
p55Q immunoprecipitates. In addition, EGF-induced tyrosine
phosphorylation was observed in p85K, p85L, p55K and p55Q, but
not in p50K, immunoprecipitates. Thus, each regulatory subunit
exhibits specific responses regarding both the association with
tyrosine-phosphorylated substrates and its own tyrosine phos-
phorylation. These results suggest that each isoform possesses
specific roles in signal transduction, based on its individual
tyrosine kinase receptor. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Many receptor tyrosine kinases (RTKs) transduce their sig-
nals via speci¢c interactions with SH2 domain-containing pro-
teins [1]. The SH2 domain-containing regulatory subunit of
phosphatidylinositol 3-kinase (PI 3-kinase) has been shown to
bind directly to the tyrosine-phosphorylated YXXM motif of
many activated RTKs [2,3]. To date, ¢ve mammalian regula-
tory subunit isoforms have been identi¢ed, including two 85
kDa proteins (p85K and p85L), two 55 kDa proteins (p55K
and p55Q), and one 50 kDa protein (p50K). All of these iso-
forms share two SH2 domains and an inter-SH2 domain but
contain di¡erent NH2-terminal sequences. The most well-
known 85 kDa isoforms, p85K and p85L, contain SH3 and
bcr homology domains in their N-termini [4^7]. The recently
cloned 55 kDa isoforms, p55K and p55Q, contain a unique 34
amino acid sequence in their N-termini [8^10]. The 50 kDa
isoform, an alternative splice variant of the p85K gene, con-
tains only a unique 6 amino acid sequence in its N-terminal
portion, which is apparently too short to interact with other
molecules [11,12].
In this study, we overexpressed these regulatory subunit
isoforms in A431 cells and Chinese hamster ovary (CHO) cells
overexpressing three distinct RTK types, insulin receptor (IR),
platelet-derived growth factor receptor (PDGFR) and epider-
mal growth factor receptor (EGFR), and examined the asso-
ciations of the regulatory subunits with these three RTKs in
response to the stimulation of each ligand. In addition, the
tyrosine phosphorylations of these regulatory subunit iso-
forms were also investigated. We herein show these di¡erences
in responses among the PI 3-kinase regulatory subunit iso-
forms for the ¢rst time. The results suggest that each regula-
tory subunit isoform plays a role in the response to individual
stimuli.
2. Materials and methods
2.1. Cell culture and preparation of cell lysates
CHO (K1) cells stably overexpressing human IR (CHO-IR) were
prepared as described previously [11]. CHO cells overexpressing
PDGF-L receptor (CHO-PDGFR) or EGFR (CHO-EGFR) were gen-
erously provided by Prof. Y. Ebina (Institute for Enzyme Research,
University of Tokushima, Japan). These CHO cells were maintained
in Ham’s F-12 containing 10% fetal calf serum at 37‡C in 5% CO2.
A431 cells, a cell line derived from a human carcinoma cell line, were
grown in Dulbecco’s modi¢ed Eagle medium containing 10% fetal calf
serum at 37‡C in 5% CO2. Prior to exposure to growth factors, the
medium was replaced with serum-free medium containing 0.2% bo-
vine serum albumin and the cells were incubated for 18 h. Then, the
corresponding growth factors were added to the medium (50 Wg/ml for
PDGF, 100 nM for insulin and 100 Wg/ml for EGF) and the cells were
incubated for 10 min at 37‡C. After stimulation, the medium was
removed and the cells were washed twice with ice-cold phosphate-
bu¡ered saline, and lysed in 5 ml of ice-cold lysis bu¡er containing
1% Nonidet P-40, 137 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 100
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WM sodium orthovanadate, and 1 mM phenylmethylsulfonyl £uoride.
The lysate was cleared by centrifugation at 14 000Ug for 10 min. The
resulting supernatants were used for the experiments.
2.2. Transient expression of regulatory subunits of PI 3-kinase with an
adenovirus expression system
The cassette cosmid for constructing recombinant adenovirus,
pAdex1wt, was a generous gift from Dr. Izumi Saito (Institute of
Medical Science, University of Tokyo). The cDNAs encoding the
full-length amino acid sequences of p85K, p85L, p55K, p55Q and
p50K, as well as the HA-tag amino acid sequence (YPYDVPDYA)
at each C-terminus, were ligated into the SwaI sites of pAdex1wt. The
cDNA encoding p110K as well as the GLUT2-tag amino acid sequen-
ces corresponding to residues 510^524 of human GLUT2 were also
ligated similarly. Recombinant adenoviruses were obtained as previ-
ously described [13]. A431 cells and CHO cells overexpressing each
RTK corresponding to one 100 mm plate (107 cells) were infected
with these viruses for 1 h, then grown for 48 h. The amounts of
each regulatory protein expressed were evaluated by immunoblotting,
using anti-HA antibody (12CA5), and the amounts were con¢rmed to
be nearly.
2.3. Immunoprecipitation and Western blotting
The resulting cell lysates were incubated with appropriate antibod-
ies. KEGFR, KPDGFR and KIR were obtained from Sigma RBI.
KHA (12CA5) was obtained from Boehringer Mannheim. Phospho-
speci¢c AKT1 (Ser473) antibody was obtained from New England
Biolabs. KGLUT2-tag and KIRS-1 were as previously described
[14,15]. Protein G-Sepharose beads were used to precipitate the im-
mune complexes. The beads were washed three times with lysis bu¡er
and the immunoprecipitated proteins were separated from the beads
by boiling in Laemmli bu¡er. The beads were removed by centrifuga-
tion, and supernatants were subjected to SDS^PAGE. Immunoblot-
ting, to detect phosphotyrosine proteins, was performed using anti-
phosphotyrosine antibody (4G10) as previously described [16]. These
experiments were performed three times.
2.4. PI 3-kinase assay
The resulting cell lysates were incubated with anti-HA antibody.
The protein G-Sepharose beads were used to precipitate the immune
complexes. The presence of PI 3-kinase activity in immune complexes
was determined as described previously [17]. Radioactivity was mea-
sured using a Molecular Imager instrument.
3. Results and discussion
3.1. Five regulatory subunits associate with PDGFR similarly
Several studies have shown a direct association between
tyrosine-phosphorylated PDGFR and p85 regulatory subunits
of PI 3-kinase [18,19]. In this study, each regulatory subunit
isoform was overexpressed in CHO-PDGFR cells. The
amounts of the regulatory protein expressed in CHO cells
were essentially equal (Fig. 1A). We stimulated these cells
with PDGF, and found PDGFR with a molecular weight of
180 kDa in the immunoprecipitate of each regulatory subunit
(Fig. 1B). PDGFRs associated with each regulatory protein
were observed to be phosphorylated when blotted with anti-
phosphotyrosine antibody (data not shown). We calculated
the ratios of the PDGFR to each regulatory subunit protein
as shown in Fig. 1C. Upon PDGF stimulation, there was no
apparent di¡erence in either the association of the ¢ve regu-
latory subunits with PDGFR, or tyrosine phosphorylation of
the regulatory subunits. These associations were also demon-
strated by reversing the immunoprecipitation experiments, in
which comparable amounts of each regulatory subunit were
detected in PDGFR immunoprecipitates (data not shown).
These results suggest that all of these regulatory subunits sim-
Fig. 1. (A) Immunoblotting of the expressed regulatory subunit proteins using anti-HA antibody. The cell lysates from CHO-PDGFR cells,
transiently expressing each of the regulatory subunits of PI 3-kinase (lane 1: Lac Z, lane 2: p85K, lane 3: p85L, lane 4: p55Q, lane 5: p55K,
lane 6: p50K), were incubated with anti-HA antibody covalently coupled to protein A-Sepharose beads. The beads were washed and the pro-
teins were separated from the beads by boiling in Laemmli bu¡er. The supernatants were then subjected to SDS^PAGE. To detect expressed
regulatory proteins, immunoblotting was performed using anti-HA antibody. (B) PDGFR in immunoprecipitates of each regulatory subunit of
PI 3-kinase. CHO-PDGFR, transiently overexpressing each regulatory subunit of PI 3-kinase (lanes 1, 2: Lac Z, lanes 3, 4: p85K, lanes 5, 6:
p85L, lanes 7, 8: p55Q, lanes 9, 10: p55K, lanes 11, 12: p50K), were incubated for 10 min in the presence (lanes 2, 4, 6, 8, 10, 12) or in the ab-
sence (lanes 1, 3, 5, 7, 9, 11) of 50 Wg/ml PDGF. The resulting cell lysates were incubated with anti-HA antibody covalently coupled to protein
A-Sepharose beads, and subjected to SDS^PAGE. Immunoblotting was performed using anti-PDGFR antibody. (C) The ratios of PDGFR to
each regulatory subunit protein, measured densitometrically, were calculated. Values are shown as percentages of the ratio of the phosphorylat-
ed proteins to p85K regulatory subunits. Data shown are means þ S.E.M.
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ilarly transmit the signal downstream via association with
PDGFR.
3.2. Lower a⁄nity of p55Q regulatory subunit for IRS-1 than
for other subunits
Tyrosine-phosphorylated proteins associating with overex-
pressed regulatory subunits of PI 3-kinase in CHO-IR cells
upon insulin stimulation were investigated by the same meth-
od. The amounts of regulatory protein expressed in CHO cells
were essentially equal (Fig. 2A). As shown in Fig. 2B, there
were two major phosphorylated proteins with molecular
weights of 180 kDa and 95 kDa, corresponding to the tyro-
sine-phosphorylated IRS-1 and IR. IRS-1 is one of the major
IR kinase substrates that undergoes tyrosine phosphorylation
and reportedly possesses four putative tyrosine residues which
bind to the SH2 domain in the regulatory subunits of PI 3-ki-
nase [20,21]. On the other hand, the IR also possesses a motif
containing Y1322, capable of binding to PI 3-kinase, in its
C-terminus [3,22]. Thus, besides PI 3-kinase binding to one
of IRS-1 and IR, it is possible that IR/IRS-1/regulatory sub-
units of PI 3-kinase form stable ternary complexes [23].
As shown in Fig. 2B, the amount of IRS-1 bound to p55Q
was much smaller than that bound to the other regulatory
subunits, while there were no signi¢cant di¡erences in the
amount of IR bound to the regulatory subunit among the
isoforms. IRS-1/regulatory subunit interactions were also
demonstrated by reversing the immunoprecipitation experi-
ments, in which small amounts of p55Q were observed in the
IRS-1 immunoprecipitates (Fig. 2D). The lowest a⁄nity of
p55Q for IRS-1 was also observed in similar experiments using
HepG2 cells, in a previous study [11]. This phenomenon sug-
gests that p55Q may mediate insulin signaling mainly via asso-
ciation with IR rather than IRS-1. In addition, a recent study
demonstrated a tight association between insulin-like growth
factor receptor and p55Q [24], also suggesting a crucial role for
p55Q as an adapter protein for insulin or the IGF receptor,
rather than IRS-1 protein.
The tyrosine phosphorylations of p85L, p55K and p55Q were
apparent in CHO-IR cells upon stimulation with insulin.
Although the tyrosine phosphorylation of p85L was observed
irrespective of insulin stimulation, taking the absence of phos-
phorylation of p85L expressed in control CHO (data not
shown) or CHO-PDGF cells into consideration, the tyrosine
phosphorylation of p85L is presumably induced by IR even in
the absence of insulin stimulation. Regarding the tyrosine
phosphorylation of p55K and p55Q, it has been shown that
Y29 and Y2/29 in the unique N-terminal sequence were the
tyrosine residues phosphorylated by IR and Tec tyrosine ki-
nase, respectively [25]. Previous studies found the putative
phosphorylation sites to be Tyr-368, 580 and 607 in p85K
[26]. As these tyrosine-containing motifs are recognized by
various SH2 proteins, it is possible that these phosphorylation
sites are linked to other SH2-containing molecules or mediate
the dimerization of regulatory subunits. As yet, no informa-
Fig. 2. (A) Immunoblotting of the expressed regulatory subunits using anti-HA antibody. The cell lysates from CHO-IR cells, transiently ex-
pressing each of the regulatory subunits of PI 3-kinase (lane 1: Lac Z, lane 2: p85K, lane 3: p85L, lane 4: p55Q, lane 5: p55K, lane 6: p50K),
were incubated with anti-HA antibody covalently coupled to protein A-Sepharose beads, and then subjected to SDS^PAGE. Immunoblotting
was performed using anti-HA antibody. (B) The phosphotyrosine proteins in immunoprecipitates of each regulatory subunit of PI 3-kinase.
CHO-IR cells, transiently overexpressing each regulatory subunit of PI 3-kinase (lanes 1, 2: Lac Z, lanes 3, 4: p85K, lanes 5, 6: p85L, lanes 7,
8: p55Q, lanes 9, 10: p55K, lanes 11, 12: p50K), were incubated for 10 min in the presence (lanes 2, 4, 6, 8, 10, 12) or in the absence (lanes 1,
3, 5, 7, 9, 11) of 100 nM insulin. The resulting cell lysates were incubated with anti-HA antibody covalently coupled to protein A-Sepharose
beads, and subjected to SDS^PAGE. Immunoblotting, to detect phosphotyrosine proteins associated with each of the expressed regulatory sub-
units, was performed using anti-phosphotyrosine antibody (4G10). (C) The ratios of the phosphorylated proteins to each regulatory subunit
protein, measured densitometrically, were calculated. Values are shown as percentages of the ratio of the phosphorylated proteins to p85K regu-
latory subunits. Data shown are means þ S.E.M. (D) Each PI 3-kinase regulatory subunit in IRS-1 immunoprecipitates. The resulting cell
lysates were immunoprecipitated with anti-IRS-1 antibody, and subjected to SDS^PAGE. Immunoblotting was performed using anti-HA anti-
body.
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tion is available on the tyrosine residue phosphorylated in the
regulatory subunit of PI 3-kinase. Further study is thus nec-
essary to clarify the biological signi¢cance of these tyrosine
phosphorylations.
3.3. EGFR associates with p85 and p50 regulatory subunits, but
not p55, upon EGF stimulation
Tyrosine-phosphorylated proteins associating with overex-
pressed regulatory subunits in CHO-EGFR cells upon EGF
stimulation were similarly assessed by anti-phosphotyrosine
immunoblotting. The amounts of the regulatory protein ex-
pressed in CHO cells were essentially equal (Fig. 3A). Upon
EGF stimulation, one major phosphorylated protein with a
molecular weight of 180 kDa was observed in immunoprecip-
itates of p85 and p50 (Fig. 3B). This protein corresponds to
the autophosphorylated EGFR. EGFR/regulatory subunit in-
teractions were detected by reversing the immunoprecipitation
experiments, in which only p85 and p50 regulatory subunits
were detected in the EGFR immunoprecipitates (Fig. 3D).
The mechanism of EGF-induced PI 3-kinase activation is
somewhat complicated. EGFR lacks a tyrosine-phosphorylat-
ed YXXM motif and direct association of PI 3-kinase with
EGFR is controversial [27,28]. Some reports suggest that
EGFR does bind with p85 regulatory subunits [29^31],
although the a⁄nity is much weaker than that with many
other tyrosine kinase receptors such as PDGFR. On the other
hand, ErbB3, c-Cbl and Gab1, substrates of EGFR, have
been shown to associate with and activate PI 3-kinase in re-
sponse to EGF stimulation [16,32,33]. Which of these adapter
proteins is/are involved in PI 3-kinase association would di¡er
among cell types. For example, in A431 cells, EGF promotes
the association of PI 3-kinase with EGFR-transactivated
ErbB3 [28], while in PC12 or A549 cells, c-Cbl has been sug-
gested to serve as an adapter protein for EGF-induced PI
3-kinase activation [32].
In CHO-EGFR cells, tyrosine phosphorylation of EGFR,
but not of Gab1 or c-Cbl (data not shown), was observed in
response to EGF stimulation. Though the reason for EGFR
not being detected in the p55 regulatory subunit immunopre-
cipitates was not clear, we speculate that the N-terminal por-
tion of p55, which is the phosphorylation site and also shows
a high a⁄nity for microtubules [34], may inhibit continuous
association with EGFR. Interestingly, both p55K and p55Q
were tyrosine-phosphorylated in response to EGF stimulation
(Fig. 3B), suggesting that the p55 regulatory subunits of PI
3-kinase may also be involved in activities downstream from
EGF signaling. We speculate that after being tyrosine-phos-
phorylated by EGFR, p55K and p55Q may be removed from
EGFR and recruited to a di¡erent portion of the cell.
We next examined whether the heterodimer p85^p110 also
binds to EGFR. When p110K was overexpressed together
with each regulatory subunit in CHO-EGFR cells, no
EGFR was detectable in the p110K immunoprecipitates,
even in the presence of EGF (data not shown). These results
agree with a previous report [4] showing that free p85, but not
the p85^p110 complex, binds to EGFR.
Fig. 3. (A) Immunoblotting of the expressed regulatory subunits using anti-HA antibody. The cell lysates from CHO-EGFR cells, transiently
expressing each of the regulatory subunits of PI 3-kinase (lane 1: Lac Z, lane 2: p85K, lane 3: p85L, lane 4: p55Q, lane 5: p55K, lane 6:
p50K), were incubated with anti-HA antibody covalently coupled to protein A-Sepharose beads, and then subjected to SDS^PAGE. Immuno-
blotting was performed using anti-HA antibody. (B) The phosphotyrosine proteins in immunoprecipitates of each regulatory subunit of PI 3-ki-
nase. CHO-EGFR cells, transiently overexpressing each regulatory subunit of PI 3-kinase (lanes 1, 2: Lac Z, lanes 3, 4: p85K, lanes 5, 6:
p85L, lanes 7, 8: p55Q, lanes 9, 10: p55K, lanes 11, 12: p50K), were incubated for 10 min in the presence (lanes 2, 4, 6, 8, 10, 12) or in the ab-
sence (lanes 1, 3, 5, 7, 9, 11) of 100 Wg/ml for EGF. The resulting cell lysates were incubated with anti-HA antibody covalently coupled to pro-
tein A-Sepharose beads, and subjected to SDS^PAGE. Immunoblotting, to detect phosphotyrosine proteins associated with each of the ex-
pressed regulatory subunits, was performed using anti-phosphotyrosine antibody. (C) The ratios of the phosphorylated EGFR to each
regulatory subunit protein, measured densitometrically, were calculated. Values are shown as percentages of the ratio of the phosphorylated
proteins to p85K regulatory subunits. Data shown are means þ S.E.M. (D) Each PI 3-kinase regulatory subunit in EGFR immunoprecipitates.
The resulting cell lysates were immunoprecipitated with anti-EGFR antibody, and subjected to SDS^PAGE. Immunoblotting was performed us-
ing anti-HA antibody.
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Similar experiments were performed using A431 cells, which
endogenously express members of the EGFR family, includ-
ing EGFR and ErbB3. The amounts of regulatory subunits
expressed in A431 cells were essentially equal (Fig. 4A). The
phosphorylated proteins with an approximate molecular
weight of 180 kDa are likely to correspond to EGFR Fig.
4B), although the possibility that this band also includes the
transactivated ErbB3 cannot be excluded as previously de-
scribed [27]. Nevertheless, in A431 cells, we obtained very
similar results regarding both the association with EGFR
and tyrosine phosphorylation of the regulatory subunit.
Taken together, these observations strongly support the con-
clusion that p85K, p85L and p50K associate directly with
EGFR, and thereby activate PI 3-kinase, while the motif con-
taining phosphorylated tyrosine in p55K and p55Q may play a
role in a cellular compartment distinct from EGFR.
3.4. Downstream signaling via each PI 3-kinase regulatory
subunit
We measured the PI 3-kinase activities associated with each
regulatory subunit, upon stimulation of each ligand, to inves-
tigate whether these activities correlate with co-immunoprecip-
itation data. We previously reported each isoform-associated
PI 3-kinase activation in response to insulin, using adenovirus
transient expression into CHO-IR cells [11]. In this study, we
performed similar experiments using CHO-PDGFR and
CHO-EGFR cells. With PDGF stimulation, the fold increases
in PI 3-kinase activation were 2.4, 1.3, 2.0, 3.6 and 10.3 for
p85K, p85L, p55Q, p55K and p50K, respectively (Fig. 5A),
whereas with EGF stimulation, the fold increases in PI 3-ki-
nase activation were 2.4, 1.6, 0.9, 0.9 and 6.8 for p85K, p85L,
p55Q, p55K and p50K, respectively (Fig. 5B). The dissociation
between PI 3-kinase activation and the binding data can be
explained as follows; although each regulatory subunit iso-
form has a similar ability to associate with the p110K catalytic
subunit, the basal PI 3-kinase activities associated with each
regulatory subunit di¡ered signi¢cantly. For example, p50K-
associated PI 3-kinase activity in the absence of ligand was
lower than those of the other isoforms, resulting in an appar-
ent marked increase in p50K-associated PI 3-kinase activation.
Fig. 4. (A) Immunoblotting of the expressed regulatory subunits using anti-HA antibody. The cell lysates from A431 cells, transiently expres-
sing each of the regulatory subunits of PI 3-kinase (lane 1: Lac Z, lane 2: p85K, lane 3: p85L, lane 4: p55Q, lane 5: p55K, lane 6: p50K), were
incubated with anti-HA antibody covalently coupled to protein A-Sepharose beads, and then subjected to SDS^PAGE. Immunoblotting was
performed using anti-HA antibody. (B) The phosphotyrosine proteins in immunoprecipitates of each regulatory subunit of PI 3-kinase. A431
cells, transiently overexpressing each regulatory subunit of PI 3-kinase (lanes 1, 2: Lac Z, lanes 3, 4: p85K, lanes 5, 6: p85L, lanes 7, 8: p55Q,
lanes 9, 10: p55K, lanes 11, 12: p50K), were incubated for 10 min in the presence (lanes 2, 4, 6, 8, 10, 12) or in the absence (lanes 1, 3, 5, 7, 9,
11) of 100 Wg/ml for EGF. The resulting cell lysates were incubated with anti-HA antibody covalently coupled to protein A-Sepharose beads,
and subjected to SDS^PAGE. Immunoblotting, to detect phosphotyrosine proteins associated with each of the expressed regulatory subunits,
was performed using anti-phosphotyrosine antibody. (C) The ratios of the phosphorylated EGFR to each regulatory subunit protein, measured
densitometrically, were calculated. Values are shown as percentages of the ratio of the phosphorylated proteins to p85K regulatory subunits.
Data shown are means þ S.E.M.
Fig. 5. Ligand-induced activation of PI 3-kinase associated with
each regulatory subunit in CHO-PDGFR (A) and CHO-EGFR (B).
We overexpressed each regulatory subunit in CHO-PDGFR or
CHO-EGFR cells. After each ligand treatment, the resulting cell ly-
sates were immunoprecipitated with anti-HA antibody and assayed
for PI 3-kinase activity as previously described. P.D., pixel density.
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Secondly, the degree of PI 3-kinase activity enhancement,
which is induced by the association with receptors, also dif-
fered signi¢cantly among the isoforms. For example, p55Q-
associated PI 3-kinase activity is not particularly high in com-
parison with that associated with p85K.
Ligand-induced activation of PI 3-kinase leads to the gen-
eration of second messengers, PI(3,4)P2 and PI(3,4,5)P3,
which play crucial roles in the activation of PKB/Akt [35].
To investigate whether there is di¡erential downstream acti-
vation of PI 3-kinase targets, we performed immunoblotting
to visualize the serine phosphorylation of Akt using phospho-
speci¢c AKT1 (Ser473) antibody. In CHO-PDGFR (data not
shown) and CHO-IR cells (Fig. 6A), the level of Akt phos-
phorylation was signi¢cantly enhanced by the overexpression
of each regulatory subunit isoform, and the degree of en-
hancement did not di¡er signi¢cantly among the ¢ve regula-
tory isoforms. p55Q exhibited lower association with IRS-1,
but a similar association with the IR, which may be the reason
for p55Q enhancing insulin-induced Akt phosphorylation to an
extent similar to that with the other isoforms. In CHO-EGFR
cells, the overexpression of p85K, p85L and p50K resulted in
an apparent enhancement of EGF-induced Akt phosphoryla-
tion, while overexpressing p55K and p55Q did not (Fig. 6B).
These results suggest the importance of the associations be-
tween regulatory subunits and the RTK, with respect to the
phosphorylation of Akt via PI 3-kinase activation.
In conclusion, this is the ¢rst report clearly demonstrating
that the ¢ve isoforms of the PI 3-kinase regulatory subunit
exhibit di¡erent associations with RTKs, as well as di¡ering
in their tyrosine phosphorylations. Although the physiological
signi¢cance of tyrosine phosphorylation in the regulatory sub-
unit remains unknown, we believe that the di¡erent associa-
tions with the individual RTKs are important. Thus, we spec-
ulate that the combination of an individual RTK and the
expression level of each regulatory subunit may determine
the degree of PI 3-kinase activation in response to the corre-
sponding growth factor stimulation.
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